CharisMab Platform for Survivor-Sourced Cancer Antibodies Antigen Identification Technology Finding Cell Surface Antigen for the Screened Antibody Successfully identified antigens for 3 antibodies discovered from triple-negative breast cancer survivors (Cetuximab, anti-CD44) Applicable for cell surface receptor discovery against novel ligands and specificity validation of novel antibodies
